The Centers for Medicare and Medicaid Services and NCI said they are developing a Memorandum of Understanding to address how the agencies can work together to improve the process for making coverage decisions for cancer therapy and diagnosis.
Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.
Access to mammography needs improvement, IOM National Cancer Policy Board report finds.
NCAB, President’s Cancer Panel honor the late Paul Calabresi.
Funding opportunities listed.
Trending Stories
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns









